Genaera
Navigation Links
Genaera in Medical News
Xmark Comments on Genaera Cost-Saving Plan
RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by G......nce companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., Cytogen Corporation and genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Schnittker also held manage...
Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
...TH MEETING, Pa., June 12 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...fer of the Company's assets and liabilities to the genaera Liquidating Trust (the "Trust"). The Trust w...l interest ("Unit") in the Trust for each share of genaera common stock then held of record by such stockhold...Genaera Corporation Announces Results of Special Meeting of Stockholders
...UTH MEETING, Pa., June 5 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...he Company (the "Plan of Dissolution). About genaera genaera Corporation has developed trodusquemine (MSI-1436)...Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors
...H MEETING, Pa., April 28 /PRNewswire-FirstCall/ -- genaera Corporation (the "Company")(Nasdaq: GENR ) today...lso be obtained by directing a written request to: genaera Corporation, Attn: Secretary, 5110 Campus Drive, P...th respect to the Plan of Dissolution. About genaera ...Genaera Corporation Implements Cash Conservation Plan
...H MEETING, Pa., March 30 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...dent and Chief Executive Officer of Genaera. genaera estimates that it will incur restructuring charges...h the reduction in force. As of December 31, 2008, genaera had cash, cash equivalents and short-term investme...Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
...TH MEETING, Pa., March 9 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced, in ...he Securities and Exchange Commission. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera Corporation Announces 2008 Financial Results
...TH MEETING, Pa., March 3 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced its ...$8.1 million at December 31, 2008. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera to Present at BIO CEO & Investor Conference
...UTH MEETING, Pa., Feb. 5 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) will present at the ..., February 10, 2009 at 2:15 p.m. (ET). About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera to Participate in Obesity Panel at RBC Capital Markets Healthcare Conference
...UTH MEETING, Pa., Dec. 4 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that... www.wsw.com/webcast/rbc95/panel6 About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera in Medical Technology
Broadens late-stage product development portfolio building on lead product candidate EcoNail in Phase 2 trial for onychomycosis
WELLESLEY HILLS, Mass., Oct. 3 /PRNewswire-FirstCall/ -- MacroChem
Corporation (OTC Bulletin Board: MACM) today announced that it has
exercised the option it ...
...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an... phase 1 clinical testing in obesity. In addition, genaera has a value-driven, fully out-licensed partnership...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...
...pated in the Phase 1 clinical program of MSI-1436. genaera plans to conduct an ascending multiple-dose study ...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...
...e asthma and exercise-induced bronchoconstriction. genaera and MedImmune entered into a research collaboratio...t multiple sites throughout the U.S. and Canada. genaera also noted that MedImmune announced preliminary sa...he U.S. at $14 billion annually. About Genaera genaera Corporation is focused on advancing the science an...
Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
...TH MEETING, Pa., Feb. 10 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today reported promi...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia
... MEETING, Pa., Jan. 22 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced a po...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
...TH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...ekly subcutaneously administered formulation which genaera expects to utilize in Phase 2 clinical trials in t...bolism and cholesterol elevation. About genaera ......olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an... phase 1 clinical testing in obesity. In addition, genaera has a value-driven, fully out-licensed partnership...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...
...pated in the Phase 1 clinical program of MSI-1436. genaera plans to conduct an ascending multiple-dose study ...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...
Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
...y of Neuroscience by Mitchell F. Roitman, Ph.D., a genaera collaborator and investigator with the University ...ry R. Wolfe, Ph.D. from Genaera. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr......e asthma and exercise-induced bronchoconstriction. genaera and MedImmune entered into a research collaboratio...t multiple sites throughout the U.S. and Canada. genaera also noted that MedImmune announced preliminary sa...he U.S. at $14 billion annually. About Genaera genaera Corporation is focused on advancing the science an...
Genaera in Biological News
Natural antibiotics yield secrets to atom-level imaging technique
...istry, the Medical School and the Biophysics Research Division, as well as collaborators in Canada, Japan, India and the U.S. pharmaceutical companies genaera Corporation and Eli Lilly and Company. Ramamoorthy was awarded support from the National Institutes of Health and the National Science Foundation, thr...Genaera in Biological Technology
Genaera Receives Non-Compliance Notice from Nasdaq
...UTH MEETING, Pa., May 27 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...has received notification from Nasdaq stating that genaera is no longer in compliance with Nasdaq Marketplace...with Nasdaq's continued listing requirements. genaera previously announced on April 28, 2009 that its Bo...Genaera to Present at BIO-Europe 2008
...overview on Tuesday, November 18, 2008 at 11:00 a.m. CET. About Genaera genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and ...e to inaccurate assumptions, unknown risks, uncertainties or other factors. genaera does not intend (and it is not obligated) to publicly update, revise or cor...Genaera Corporation Announces Second Quarter Financial Results
... $12.8 million at June 30, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...Genaera Corporation Elects Paul K. Wotton to Board of Directors
...am very pleased to join Genaera's Board. I believe genaera has the opportunity to develop MSI-1436 as a novel...owing metabolic disease market." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...Genaera Corporation to Present at BIO Business Forum
...iego Convention Center, Room 30A About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...Genaera Corporation Announces First Quarter Financial Results
...$17.1 million at March 31, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...Genaera Corporation Announces 2007 Financial Results
... be a pivotal year for Genaera." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product......ing webcast at: http:/www.wsw.com/webcast/rbc84qpanel23 About Genaera genaera Corporation is focused on advancing the science and treatment of metabolic ...re program that is presently undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core program and the aggressive ...
Genaera Corporation Announces Third Quarter Financial Results
...estone targets to drive shareholder value." About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...Genaera to Present at Biotech 2007 and BIO InvestorForum
...(5:00 PM ET) on Thursday, October 11, 2007. About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...Other TagsCystoDispoablePrefilledCDNCDNiLEDiLEDiLEDOther Contentsprostaglandinsprostaglandinsprostateprostateprostateprostateprostateprostateprostatearrayarrayarrayarrayarrayarrayarrayarrayfoldingfoldingfoldingfoldingfoldingfoldingprotistaprotocellsprotonsprotonsprotonsprotons
CystoUroViewDispoablePrefilledEntrainmentCDNiLEDCelestialSkytronFlatscreenPrismAlixU100PlusEndovascularAAA
(Date:12/2/2009)...wswire/ - As part of its continued commitment to h... of Pfizer, has pledged more than 40 million inter... World Federation of Hemophilia (WFH). This is the...ian Aid Program, and will make a significant impac... will directly support building sustainable nation...
(Date:12/2/2009)... Independence Blue Cross (IBC) toda...Lincoln Financial Group. IBC will be the primary p...00 Lincoln Financial Group employees, retirees, an...plan offerings will include the PPO option and Com...eak for all of us at Independence Blue Cross when ...
(Date:12/2/2009).... 2 TeamHealth ( www.teamhealth.co... the acquisition of Naples-based Emergency Physici... has held an exclusive contract with NCH Healthcar...Downtown Naples Hospital, North Naples Hospital, a...the staffing for two stand-alone urgent care clini...
(Date:12/2/2009)...sports. An avid tennis player and golfer, as well ...ecame increasingly frustrated over time as his eye...e disorder. Unable to return the tennis ball or se...t of a corneal transplant to restore his vision an...iscovered an alternative treatment. He received a ...
(Date:12/2/2009)...ngress of the European Association of Echocardiogr...ciety of Cardiology, where techniques of non-invas... case reports will be presented at this year,s Con...ole of this new technology. , Now, with such ra...y that non-invasive imaging will gain more importa...
Breaking Medicine News(10 mins):Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2[0] The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH[0] Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group[0] TeamHealth Acquires Emergency Physicians of Naples, LLC[1] Brandeis studies evaluate visionary approach to improving eyesight[0] Media alert: EUROECHO 2009
(Date:12/1/2009)...ening to the radio anymore. They,re used in everyt...m North Carolina State University is revolutionizi...fting antennas that open the door to a host of new...tary deployment. , Modern antennas are made from... to how far they can be bent and how often befor...
(Date:11/30/2009)...s needed to monitor the commitments that will be m...heir deforestation rates, according to research at...agencies and research groups have failed to make f...e Earth,s surface collected each week to monitor t...r Alan Grainger in the Proceedings of the Nationa...
(Date:11/30/2009)...nd dessert at the holiday table are even less of a...ccording to a new research report recently appeari...bj.org ), a diet that is high in fat and in sugar ...ur bodies to store too much fat. This means these ...difficult task of converting high-fat and high-sug...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2World forest observatory needed to monitor vital role of forests in climate deal 2Happy holidays from the groaning board; Western diets turn on fat genes 2 Acupuncture May Relieve Heartburn In Pregnancy 48380 1 Acupuncture May Relieve Heartburn In Pregnancy 48380 2 Acupuncture May Relieve Heartburn In Pregnancy 48380 3Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 1Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 2Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 3DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 1DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 2DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 48372 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |